4//SEC Filing
Ohr Pharmaceutical Inc 4
Accession 0001387131-16-006267
CIK 0001173281operating
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 12:15 PM ET
Size
6.6 KB
Accession
0001387131-16-006267
Insider Transaction Report
Form 4
Slakter Jason Scott
Director
Transactions
- Other
Common Stock, par value $0.0001 per share
2016-07-18+497,859→ 1,195,724 total(indirect: By LLC)
Holdings
- 925,040
Common Stock, par value $0.0001 per share
Footnotes (1)
- [F1]SKS Ocular I LLC directly owns the shares of Common Stock. On May 30, 2014, the Issuer completed an ophthalmology assets acquisition of SKS Ocular LLC and SKS Ocular I LLC. Pursuant to the acquisition agreement, among other things, SKS Ocular I LLC is eligible to receive additional shares of Common Stock in three contingent milestone payments. Milestones 1 and 2 have been met and the Issuer issued 497,859 shares of Common Stock to SKS Ocular I LLC on each of December 15, 2015 and July 18, 2016. The Reporting Person has investment and voting power with respect to the Common Stock held by SKS Ocular 1 LLC. Therefore, the Reporting Person may be deemed to beneficially own the shares of Common Stock beneficially owned by SKS Ocular 1 LLC. The Reporting Person disclaims any beneficial ownership of the Common Stock directly owed by SKS Ocular I LLC except to the extent of his pecuniary interest therein.
Documents
Issuer
Ohr Pharmaceutical Inc
CIK 0001173281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001173281
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 12:15 PM ET
- Size
- 6.6 KB